+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years - 80Years
All Genders
ID07182422

Study of AST-120 Kremezin to Protect Kidneys and Lower Toxin Levels in Adults with Acute Kidney Disease

Led by Chang Gung Memorial Hospital · Updated on 2025-09-19

100

Participants Needed

1

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the use of AST-120 Kremezin4 combined with standard care to reduce protein-bound uremic toxins, specifically indoxyl sulfate IS and p-cresyl sulfate p-CS, in patients with acute kidney disease AKD. The study aims to determine if AST-120 can help prevent worsening kidney function and slow the progression from AKD to chronic kidney disease CKD. Additionally, the trial will explore whether lowering these toxins may reduce the risk of CKD-related complications such as cardiovascular disease. The study will include 100 patients randomized into two groups one receiving AST-120 at 6 grams per day divided into three doses along with standard post-AKD care, and the other receiving only standard care. The treatment phase lasts 14 days, followed by blood tests and clinical assessments at baseline, day 14, day 90, and day 180. These tests will measure toxin levels, kidney function, and urine markers. Monitoring for major adverse kidney and cardiovascular events will also occur during follow-up visits. Participants will provide blood samples at four key timepoints to assess indoxyl sulfate, p-cresyl sulfate, serum creatinine, estimated glomerular filtration rate eGFR, and urine albumin-to-creatinine ratio UACR. Demographic and clinical data will be collected at the start. The trial includes regular health assessments and adverse event monitoring throughout. The primary measure is the change in serum indoxyl sulfate levels, with additional kidney function and toxin markers tracked over six months.

CONDITIONS

Brief Title

AST-120 (Kremezin®) for the Renal Protection and Attenuation of Decline in Acute Kidney Disease

Research Team

C

Chih-Hsiang Chang

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here